Literature DB >> 18485541

Synthesis and antiproliferative activity of 3-amino-N-phenyl-1H-indazole-1-carboxamides.

Demetrio Raffa1, Benedetta Maggio, Stella Cascioferro, Maria Valeria Raimondi, Domenico Schillaci, Giorgio Gallo, Giuseppe Daidone, Salvatore Plescia, Fiorella Meneghetti, Gabriella Bombieri, Antonietta Di Cristina, Rosaria M Pipitone, Stefania Grimaudo, Manlio Tolomeo.   

Abstract

A series of new 3-amino-N-phenyl-1H-indazole-1-carboxamides 10 have been prepared from commercially available phenyl isocyanate precursors 8 and 3-aminoindazole 9. Some of the synthesized compounds were evaluated for their in vitro antineoplastic activity against 60 human cell lines derived from seven clinically isolated cancer types (lung, colon, melanoma, renal, ovarian, brain, and leukemia) according to the NCI standard protocol. The test results indicated that 3-amino-1H-indazole-1-carboxamides 10 were endowed with an interesting antiproliferative activity. The most active compounds of this series, 10d,e, were able to inhibit cell growth of many neoplastic cell lines at concentrations lower than 1 microM (0.0153 microM in SR leukemia) causing a block in G0-G1 phase of cell cycle. Analysis of pRb expression showed that these two compounds increased the ratio between underphosphorylated pRb and total pRb. The X-ray structure of 10w, confirmed the 3-amino-N-phenyl-1H-indazole-1-carboxamide structure of compounds 10.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18485541     DOI: 10.1016/j.ejmech.2008.03.023

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  4 in total

1.  Unprecedented rearrangement of 2-(2-aminoethyl)-1-aryl-3,4-dihydropyrazino[1,2-b]indazole-2-ium 6-oxides to 2,3-dihydro-1H-imidazo[1,2-b]indazoles.

Authors:  Jan Kocí; Allen G Oliver; Viktor Krchnák
Journal:  J Org Chem       Date:  2010-01-15       Impact factor: 4.354

2.  Synthesis and anti-proliferative activity evaluation of N3-acyl-N5-aryl-3,5-diaminoindazole analogues as anti-head and neck cancer agent.

Authors:  Jinho Lee; Jina Kim; Victor Sukbong Hong; Jong-Wook Park
Journal:  Daru       Date:  2014-01-06       Impact factor: 3.117

3.  Crystal structure of 2-[2-(2,5-di-chloro-benz-yloxy)-2-(furan-2-yl)eth-yl]-2H-indazole.

Authors:  Özden Özel Güven; Gökhan Türk; Philip D F Adler; Simon J Coles; Tuncer Hökelek
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2016-09-05

4.  2-(2H-Indazol-2-yl)-1-phenyl-ethanone.

Authors:  Ozden Ozel Güven; Gökhan Türk; Philip D F Adler; Simon J Coles; Tuncer Hökelek
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-01-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.